Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anat Levit

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Nature|February 22, 2018
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidoneSheng Wang, Tao Che, Anat Levit, et al.
Biochimica Et Biophysica Acta. General Subjects|July 17, 2018
Reengineering the ligand sensitivity of the broadly tuned human bitter taste receptor TAS2R14Stefanie Nowak, Antonella Di Pizio, Anat Levit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 29, 2013
The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14Anat Levit, Stefanie Nowak, Maximilian Peters, et al.
Science (New York, N.Y.)|June 22, 2019
Structural identification of a hotspot on CFTR for potentiationFangyu Liu, Zhe Zhang, Anat Levit, et al.
Frontiers in Molecular Biosciences|September 27, 2018
Corrigendum: Independent Evolution of Strychnine Recognition by Bitter Taste Receptor SubtypesAva Yuan Xue, Antonella Di Pizio, Anat Levit, et al.
Frontiers in Molecular Biosciences|March 20, 2018
Independent Evolution of Strychnine Recognition by Bitter Taste Receptor SubtypesAva Yuan Xue, Antonella Di Pizio, Anat Levit, et al.
Human Genetics|June 20, 2006
A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophreniaSagiv Shifman, Anat Levit, Mao-Liang Chen, et al.
Pharmacogenetics and Genomics|April 15, 2008
Stargazin involvement with bipolar disorder and response to lithium treatmentGilad Silberberg, Anat Levit, David Collier, et al.
Science (New York, N.Y.)|October 21, 2017
D<sub>4</sub> dopamine receptor high-resolution structures enable the discovery of selective agonistsSheng Wang, Daniel Wacker, Anat Levit, et al.
Journal of Medicinal Chemistry|February 23, 2022
Structure-Based Design of a Chemical Probe Set for the 5-HT<sub>5A</sub> Serotonin ReceptorAnat Levit Kaplan, Ryan T Strachan, Joao M Braz, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Nature|February 22, 2018
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidoneSheng Wang, Tao Che, Anat Levit, et al.
Biochimica Et Biophysica Acta. General Subjects|July 17, 2018
Reengineering the ligand sensitivity of the broadly tuned human bitter taste receptor TAS2R14Stefanie Nowak, Antonella Di Pizio, Anat Levit, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 29, 2013
The bitter pill: clinical drugs that activate the human bitter taste receptor TAS2R14Anat Levit, Stefanie Nowak, Maximilian Peters, et al.
Science (New York, N.Y.)|June 22, 2019
Structural identification of a hotspot on CFTR for potentiationFangyu Liu, Zhe Zhang, Anat Levit, et al.
Frontiers in Molecular Biosciences|September 27, 2018
Corrigendum: Independent Evolution of Strychnine Recognition by Bitter Taste Receptor SubtypesAva Yuan Xue, Antonella Di Pizio, Anat Levit, et al.
Frontiers in Molecular Biosciences|March 20, 2018
Independent Evolution of Strychnine Recognition by Bitter Taste Receptor SubtypesAva Yuan Xue, Antonella Di Pizio, Anat Levit, et al.
Human Genetics|June 20, 2006
A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophreniaSagiv Shifman, Anat Levit, Mao-Liang Chen, et al.
Pharmacogenetics and Genomics|April 15, 2008
Stargazin involvement with bipolar disorder and response to lithium treatmentGilad Silberberg, Anat Levit, David Collier, et al.
Science (New York, N.Y.)|October 21, 2017
D<sub>4</sub> dopamine receptor high-resolution structures enable the discovery of selective agonistsSheng Wang, Daniel Wacker, Anat Levit, et al.
Journal of Medicinal Chemistry|February 23, 2022
Structure-Based Design of a Chemical Probe Set for the 5-HT<sub>5A</sub> Serotonin ReceptorAnat Levit Kaplan, Ryan T Strachan, Joao M Braz, et al.
Pageof 3